Articles

Some online health clinics are advertising and selling compounded medicines. However, it is important to know that compounded products are not identical to TGA approved products.

Companies supplying medicines in Australia will be required to provide additional information if their products go into shortage.

From 22 March 2023 changes to the Therapeutic Goods Act 1989 will help alleviate the effects of medicine shortages on patients.

The TGA is aware of several scams targeting consumers seeking semaglutide (Ozempic). Consumers are strongly advised not to use products unless they have come from a trusted source.

Supplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time.

Current antibiotics shortages in Australia include amoxicillin, amoxicillin/clavulanic acid, cefalexin, metronidazole and trimethoprim.

A warning to social media influencers and advertisers not to advertise this prescription medicine.

TGA has published a Joint statement on supply allocations of intravenous tocilizumab (Actemra) during serious shortage.

We are improving the Medicine Shortages IT System.

Pharmacies can return children's paracetamol liquid formulations to front-of-counter, but the one unit limit on sales remains in place

Stockpiling medicines may disrupt access to vital medicines by patients and pharmacies